Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Rectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02519582
What this trial is testing

Drug Trial to Investigate the Safety and Efficacy of Niclosamide Tablets in Patients With Metastases of a Colorectal Cancer Progressing After Therapy

Who this might be right for
Colorectal Cancer
Charite University, Berlin, Germany 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07509424
What this trial is testing

Neoadjuvant Short-course Radiotherapy Followed by a Combination of Disitamab Vedotin, Sintilimab, and Capecitabine in Locally Advanced HER2-expressing Rectal Cance

Who this might be right for
Rectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 29
Early research (Phase 1)Study completedNCT00019110
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

Who this might be right for
Anal CancerCervical CancerEsophageal Cancer+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT05136326
What this trial is testing

Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal Cancer

Who this might be right for
Rectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 21
Early research (Phase 1)Not Yet RecruitingNCT07014878
What this trial is testing

DCTY1102 Injection in Participants With Advanced Solid Tumors

Who this might be right for
Colorectal CancerLung CancerPancreatic Cancer
Beijing DCTY Biotech Co.,Ltd. 18
Testing effectiveness (Phase 2)Looking for participantsNCT06356584
What this trial is testing

Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases

Who this might be right for
Colorectal CancerImmunotherapyRadiotherapy+2 more
Shandong Cancer Hospital and Institute 62
Not applicableUnknownNCT03975452
What this trial is testing

Volume De-escalation in Neoadjuvant Radiochemotherapy of Rectal Cancer

Who this might be right for
Toxicity
Campus Bio-Medico University 52
Testing effectiveness (Phase 2)Looking for participantsNCT07202364
What this trial is testing

YL202 in Patients With Advanced Solid Tumors

Who this might be right for
Non Small Cell Lung CancerColorectal CancerCervical Cancer+1 more
MediLink Therapeutics (Suzhou) Co., Ltd. 100
Testing effectiveness (Phase 2)UnknownNCT03150706
What this trial is testing

Avelumab for MSI-H or POLE Mutated Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Asan Medical Center 33
Not applicableStudy completedNCT00003648
What this trial is testing

Genetic Study of Patients and Families With a History of Colorectal Cancer

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 1,500
Testing effectiveness (Phase 2)Study completedNCT00033748
What this trial is testing

Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 56
Testing effectiveness (Phase 2)Study completedNCT02278133
What this trial is testing

Study of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway Mutations

Who this might be right for
Metastatic Colorectal Cancer
Array BioPharma 20
Testing effectiveness (Phase 2)Looking for participantsNCT02919644
What this trial is testing

Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.

Who this might be right for
Stage IV Colorectal CancerCurative Resection
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 19
Not applicableStudy completedNCT02148406
What this trial is testing

Programs to Support You During Chemotherapy (Pro-You)

Who this might be right for
Depressive SymptomsFatiguePsychosocial Effects of Cancer and Its Treatment+16 more
Vanderbilt-Ingram Cancer Center 3
Testing effectiveness (Phase 2)Looking for participantsNCT01174121
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

Who this might be right for
Metastatic Colorectal CancerMetastatic Pancreatic CancerMetastatic Ovarian Cancer+2 more
National Cancer Institute (NCI) 332
Testing effectiveness (Phase 2)UnknownNCT03729687
What this trial is testing

Short Course Radiation Therapy Followed by Pre-operative Chemotherapy and Surgery in High-risk Rectal Cancer

Who this might be right for
Rectal Cancer
Uppsala University 280
Early research (Phase 1)Study completedNCT02270606
What this trial is testing

Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the RectumRecurrent Rectal CancerSignet Ring Adenocarcinoma of the Rectum+7 more
Virginia Commonwealth University 14
Testing effectiveness (Phase 2)Looking for participantsNCT06162650
What this trial is testing

Total Neoadjuvant Therapy in Rectal Cancer

Who this might be right for
Rectal Cancer
National Cheng-Kung University Hospital 42
Large-scale testing (Phase 3)Study completedNCT00025090
What this trial is testing

Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer

Who this might be right for
Anal Cancer
University College London (UCL) Cancer Institute 600
Testing effectiveness (Phase 2)Study completedNCT01462513
What this trial is testing

L-BLP25 in Patients With Colorectal Carcinoma After Curative Resection of Hepatic Metastases

Who this might be right for
Colon CarcinomaRectum Carcinoma
Prof. Dr. Carl Schimanski 122
Next Page